RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Diabetic Cardiomyopathies
Accession: DOID:9006945
browse the term
Definition: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
Synonyms: exact_synonym: Diabetic Cardiomyopathy
xref: EFO:1001458 ; MESH:D058065
G
A2m
alpha-2-macroglobulin
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21742475
RGD:10046044
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Ace
angiotensin I converting enzyme
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:22595130
RGD:9685456
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:22595130
RGD:9685456
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Acot1
acyl-CoA thioesterase 1
IMP
associated with type 2 diabetes mellitus
RGD
PMID:23226270
RGD:13831128
NCBI chr12:84,056,276...84,064,444
Ensembl chr12:84,056,264...84,065,145
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
associated with Diabetes Mellitus, Type2;mRNA, protein:decreased expression:heart, serum
RGD
PMID:24669271
RGD:8695938
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor1
adiponectin receptor 1
ISO
associated with Diabetes Mellitus, Type2;mRNA, protein:decreased expression:heart, serum
RGD
PMID:24669271
RGD:8695938
NCBI chr 1:134,343,116...134,361,089
Ensembl chr 1:134,343,116...134,361,089
G
Ager
advanced glycosylation end product-specific receptor
treatment
ISO
associated with Diabetes Mellitus, Experimental; mRNA, protein:increased expression:heart (rat)
RGD
PMID:23251674 PMID:23251674
RGD:7244283 , RGD:7244283
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29353218
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Agtr2
angiotensin II receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15587404 PMID:16025228
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
G
Akt1
thymoma viral proto-oncogene 1
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Apoa1
apolipoprotein A-I
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18332268
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Atf6
activating transcription factor 6
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
G
Atp2a2
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
ISO
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16685413 PMID:21441944
RGD:6771209
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
G
Atp7a
ATPase, copper transporting, alpha polypeptide
treatment
ISO
RGD
PMID:24927960
RGD:11341676
NCBI chr X:105,070,830...105,171,766
Ensembl chr X:105,070,882...105,168,532
G
Bad
BCL2-associated agonist of cell death
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21296063
RGD:10053697
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO IEP
associated with Diabetes Mellitus, Experimental associated with Diabetes Mellitus, Experimental;protein:increased phosphorylation:myocardium (mouse)
RGD
PMID:21296063 PMID:21474815
RGD:10053697 , RGD:11522727
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Brd4
bromodomain containing 4
ISO
mRNA,protein:increased expression:heart
RGD
PMID:30483785
RGD:597830144
NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696
G
Casp12
caspase 12
treatment
ISO
associated with Experimental Diabetes Mellitus
RGD
PMID:26869403
RGD:13782171
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:28992627
RGD:13782299
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:28992627
RGD:13782299
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
treatment
ISO
RGD
PMID:28992627
RGD:13782299
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Casq2
calsequestrin 2
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21441944
RGD:6771209
NCBI chr 3:101,993,731...102,053,830
Ensembl chr 3:101,993,731...102,053,830
G
Casr
calcium-sensing receptor
ISO
protein:decreased expression:myocardium (rat)
RGD
PMID:22137362
RGD:7205677
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
G
Cfl1
cofilin 1, non-muscle
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:27576917
RGD:11568692
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Ctnnb1
catenin beta 1
ISO
mRNA,protein:increased expression:heart
RGD
PMID:25586361
RGD:13524855
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Ddit3
DNA-damage inducible transcript 3
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
associated with Diabetes Mellitus, Experimental;mRNA:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193
RGD:10449013
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
associated with Diabetes Mellitus, Experimental;mRNA:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193
RGD:10449013
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
H19
H19, imprinted maternally expressed transcript
ameliorates
ISO IMP
RGD
PMID:27796346 PMID:36044268 PMID:27903964
RGD:156430325 , RGD:156430337 , RGD:156451660
NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,133,957
G
Hmox1
heme oxygenase 1
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:23853776 PMID:23453443
RGD:9586347 , RGD:10412713
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hsp90b1
heat shock protein 90, beta (Grp94), member 1
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373
G
Hspa5
heat shock protein 5
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11375343
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf2r
insulin-like growth factor 2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36462176
NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:23843977
RGD:7247697
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Ins1
insulin I
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:6225876
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Ins2
insulin II
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20828608
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Klk1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16129698
NCBI chr 7:43,874,784...43,879,046
Ensembl chr 7:43,874,784...43,879,042
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35235096
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
ISO
associated with type 2 diabetes mellitus;protein:decreased expression:myocardium of ventricle (rat)
RGD
PMID:22146585
RGD:155883162
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:25907942
RGD:13800893
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:25907942
RGD:13800893
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mir140
microRNA 140
ameliorates
IEP
RGD
PMID:36044268 PMID:31078585
RGD:156430337 , RGD:329347833
NCBI chr 8:108,277,876...108,277,945
Ensembl chr 8:108,277,876...108,277,945
G
Mtor
mechanistic target of rapamycin kinase
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Myc
myelocytomatosis oncogene
ISO
mRNA,protein:increased expression:heart
RGD
PMID:30483785
RGD:597830144
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Mylk2
myosin, light polypeptide kinase 2, skeletal muscle
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:9005973
RGD:1580244
NCBI chr 2:152,753,265...152,764,985
Ensembl chr 2:152,753,272...152,764,988
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment ameliorates
ISO IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:23453443 PMID:23353773 PMID:36044268
RGD:10412713 , RGD:10412721 , RGD:156430337
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:29274332
RGD:13504685
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Notch1
notch 1
treatment
ISO
RGD
PMID:32828943
RGD:405650202
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
G
Nppa
natriuretic peptide type A
treatment
ISO
associated with Diabetes Mellitus, Experimental mRNA,protein:increased expression:heart
RGD
PMID:23497378 PMID:30483785
RGD:7297056 , RGD:597830144
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nrg1
neuregulin 1
treatment
ISO
associated with Diabetes Mellitus, Experimental;protein:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193 PMID:32828943
RGD:10449013 , RGD:405650202
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ameliorates
IEP
RGD
PMID:36044268
RGD:156430337
NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
G
Pln
phospholamban
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:heart left ventricle
RGD
PMID:22185592
RGD:7327207
NCBI chr10:53,213,782...53,222,095
Ensembl chr10:53,213,763...53,222,083
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
RGD
PMID:19317897
RGD:5509944
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Ryr2
ryanodine receptor 2, cardiac
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16685413
NCBI chr13:11,567,985...12,121,831
Ensembl chr13:11,567,988...12,121,831
G
Slc25a4
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18945756
NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
G
Slc8a1
solute carrier family 8 (sodium/calcium exchanger), member 1
treatment
ISO
RGD
PMID:27058979
RGD:13628396
NCBI chr17:81,680,534...82,045,816
Ensembl chr17:81,680,534...82,045,806
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16980342
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Tert
telomerase reverse transcriptase
treatment
ISO
associated with Diabetes Mellitus, Type 2
RGD
PMID:21264070
RGD:11038677
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17909696
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Xdh
xanthine dehydrogenase
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:23843977
RGD:7247697
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all